Penny Stocks

Comment

Comment by Gerry Gallagher on August 15, 2010 at 11:22am

[b]Proton Laboratories Inc., (PLBI.PK),[/b] through Regenobody S.A. ("Regenobody"), a Dominican Republic ("DR") company has been licensed by the DR government to investigate, experiment, treat and develop autologus stem cells for regenerating one's own cellular tissues. Regenobody has the exclusive rights in its territory to the RNL BIO Company Ltd. of Korean systems and equipment for the banking, manufacture and right to purchase stem cells from RNL-BIO for a period of 20 years. The license extends to all of the Caribean, Central and South America. RNL-BIO Company Ltd. of Korea is the holder of the world wide patents relating to the harvesting, cultivation and implantation of autologus and adipose tissue derived mesenchymal stem cells and the equipment necessary to utilize the patented process.
Regenobody is expected to commence it's stem cell therapy and treatmentst in the DR in early September, 2010 under the 20 year exclusive regional territory license from RNL-BIO mentioned previously.Many are positionining themselves between now and the opening of the DR facilities when stock prices should reflect the new and exciting services, treatments and thrapies that PLBI has to offer through it's Regenobody division.

Comment by Gerry Gallagher on August 5, 2010 at 5:55pm

PLBI is now listed as a STRONG BUY on the barchart website so have a look and pass on the good news: http://www.barchart.com/quotes/stocks/PLBI

Comment by Gerry Gallagher on August 4, 2010 at 4:59pm

PLBI - Nice day today for PLBI ... up 22.22%. Indicators lead to early September opening of the new facilities and services in the Dominican Republic and new $3 Million investment. So, as I have been saying for some time now, position yourself now for what should be a fabulous ride commencing early September. The sooner you get in, the better the price you will get. This is not a PUMP & DUMP stock, it is a stock that should grow substantially and possibly back to it's high of the year of .03 or almost 300 times current or even to it's all time high of almost $3 or almost 3,000 times current. Even if it only doubles this is a great stock for you to be involved with over the next 3 to 18 months. If you have already purchased stock in PLBI you are already well positioned and holding. For those who have not yet bought PLBI stock for a potential profit over the next 3 to 18 months, please see the most recent milestones that PLBI are accomplishing and please note that the new operations in the Dominican Republic are scheduled to open in early September! So, now is the time to get positioned ... or even to increase your holding of PLBI stock.

AGAIN HERE ARE SOME OF THE CURRENT PLBI GUIDELINES FOR LONG TERM GROWTH:

PLBI MILESTONES:

-- PLBI/RegenoBody's stem cell technology patent purchase for $2 Million Dollars including the rights to South America, the Caribbean and Mexico;

-- PLBI/RegenoBody Investment in the clinic with the hiring of Dr. Keunmyuong Lee to supervise the installation;

-- PLBI/RegenoBody payment of the first two installments on the clean lab;

-- PLBI/RegenoBody expects the lab to be completed and the Company operational by early September based on promises from its laboratory equipment and set up supplier; The company is now on track to accomplish its goals of helping build a better life for its clients and families in need.

-- With almost 3 Million dollars invested to date, PLBI/RegenoBody is determined to become the Southern Hemisphere's leader in non-invasive, non-controversial stem cell technology and treatment.

Comment by Gerry Gallagher on August 1, 2010 at 7:53pm

PLBI MILESTONES:

-- PLBI/RegenoBody's stem cell technology patent purchase for $2 Million Dollars including the rights to South America, the Caribbean and Mexico;

-- PLBI/RegenoBody Investment in the clinic with the hiring of Dr. Keunmyuong Lee to supervise the installation;

-- PLBI/RegenoBody payment of the first two installments on the clean lab;

-- PLBI/RegenoBody expects the lab to be completed and the Company operational by early September based on promises from its laboratory equipment and set up supplier;

-- The company is now on track to accomplish its goals of helping build a better life for its clients and families in need. With almost 3 Million dollars invested to date, PLBI/RegenoBody is determined to become Southern Hemisphere's leader in non-invasive, non-controversial stem cell technology and treatment.

Comment by Gerry Gallagher on July 29, 2010 at 9:53pm

PLBI was up for the day (+11.11%). Started off down a point and stayed pretty much that way all day until late trading pushed it from .0080 to .0090 to .0095 then finally settling in just before the close at 0.10. I see this as a long term investment as this company has great potential in the stem cell field and has a been granted a license in The Dominican Republic, Gained License for stem cell Intellectual Propety (IP) from South Korea and the new owner has pumped between 2 and 3 million dollars into the company after buying the Dominican Republic based RegenoBody clinic and having sucessfully undergone the RegenoBody stem cell treatment himself. PLBI through it's RegenoBody division has now set itself up to be the premier stem cell clinic for the huge and profitable market of North, Central and South America.

Comment by Gerry Gallagher on July 27, 2010 at 7:15pm

PLBI - Proton Laboratories, Inc. - OTCBB

Interesting day of trading for PLBI. Early strength took the price to a day high of .014 in early trading and then it settled back to .012 most of the rest of the day. A late sale dropped the stock to 0.0071 as someone obviously sold out their holding for whatever reason but the buyers were there and waiting to almost immediately return the stock to 0.12 where is closed on the day. So, no increase nor decrease in the price but an obvious bargain for some buyers who picked off prices of 0.0071 back up to 0.12 when those shares became available. 414,467 total shares traded and it appears that most buyers are positioning themselves and holding for a potential long run upwards for this stock.

Comment by Gerry Gallagher on July 26, 2010 at 6:26pm

PLBI - Proton Laboratories - GET ON THIS STOCK AND HOLD ... A lot of positioning today (July 26, 2010) on PLBI stock. Over 1.7 Million volume with most of that being in the first hour of trading when 1.3 Million shares traded. Some early selling for profit but the stock price maintained its 0.012 price and many have now positioned themselves in this stock. I envision this to be the case all week with serious moves upcoming. I see this stock exploding and moving up quickly. Get on this stock and hold it. This is going to be a big producer over the next few weeks and really a star over the next year to 18 months. Rumors have it that the stem cell portion of the company (Regenbody) is getting very serious attention from Europe and patients seeking their Stem cell treatment in the Dominican Republic. AGAIN, get on this stock it is destined to move upwards long and strong!

Comment by Gerry Gallagher on July 26, 2010 at 10:32am

LBI opened with a volume of 1.3 Million in the first hour. Hope you all got on this one as it looks like a strong ride! Gerry

Comment by Gerry Gallagher on July 25, 2010 at 10:18am

PLBI ... Aggressive Upward Movement ... Buy and Hold

Get on PLBI "Heavy and Hold" as this stock is on an aggressive upward move. Don't miss out on this!


Proton Laboratories, Inc./RegenoBody CEO Announces Strategic Milestones are on Track

Press Release Source: Proton Laboratories, Inc. On Friday July 23, 2010, 8:00 am EDT
SOSUA BAY, Dominican Republic, July 23, 2010 (GLOBE NEWSWIRE) -- Proton Laboratories, Inc. (Pink Sheets:PLBI - News) CEO, Armando Casciati, announced today that the strategic milestones set for PLBI are on track and coming to fruition. During a statement made today, Mr. Casciati stated, "We believe our Company is fulfilling its obligations and milestones set to increase stockholder wealth with the construction of the clinic. Although we were held back by the restructuring of the convertible shares and compiling required information for Pink OTC Markets information reports, we are building upon all aspects of the company including:

PLBI/RegenoBody's stem cell technology patent purchase for $2 Million Dollars including the rights to South America, the Caribbean and Mexico;
PLBI/RegenoBody Investment in the clinic with the hiring of Dr. Keunmyuong Lee to supervise the installation;
PLBI/RegenoBody payment of the first two installments on the clean lab;
PLBI/RegenoBody expects the lab to be completed and the Company operational by early September based on promises from its laboratory equipment and set up supplier;
The company is now on track to accomplish its goals of helping build a better life for its clients and families in need. With almost 3 Million dollars invested to date, PLBI/RegenoBody is determined to become Southern Hemisphere's leader in non-invasive, non-controversial stem cell technology and treatment.
About Proton Laboratories, Inc. and its wholly owned subsidiary
RegenoBody S.A:

RegenoBody S.A., a wholly owned subsidiary of Proton Laboratories, Inc., brings the benefits of bioscience to patients who have been diagnosed with chronic debilitating diseases, offering viable, efficient therapeutic options with special Stem Cell Therapies utilizing the most potent cells in the world today. Therapies are tailored for each individual, based upon their specific needs. Cells are obtained by the most modern technologic methods. The transplant physicians and stem cell laboratory scientists, associated with RNL Bio have been regarded as some of the best in the world. Stem cells derived from Autologous (Stem cells taken from your own body) and Allogeneic (Stem cells from a source other than your own) are used depending on the particular condition that needs to be treated. Treatments will be delivered by an experienced team of International and U.S. Board Certified Physicians who are guided by strict protocols ensuring excellence in medical care.

About RNL Bio Company LTD:
RNL Bio is a premier biopharmaceutical company focused on development and commercialization of adult stem cell therapeutics and dog cloning technology. Headquartered in Seoul with a state-of-the-art GMP facility, RNL is a publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.

FORWARD-LOOKING STATEMENT:
This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this report are made as of the date hereof and the company undertakes no obligation to update such statements

Comment by Robbob on December 30, 2009 at 2:48pm

CPFR.PK Monster

Market cap 50 k !! Just 23,7 mil shares out. Reverse merger likely, would be a 100 bagger easily.NITE bought a 13% stake !!! Read here:

"Immediately after the consummation of the asset sale, the Company had no operating business or sources of revenues. The board of directors is evaluating several possible options, including offering the Company as a public "shell" corporation to a private operating business whereby the Company's current shareholders would retain some ownership interest in the surviving public corporation."

• ‹ Previous
• 1
• 2
• 3
• …
• 5
• Next ›
• Page